Navigation Links
Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
Date:2/20/2008

licensing of novel cancer therapeutics. Sunesis is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.

SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.

Safe Harbor Statement

This press release contains forward-looking statements regarding Sunesis' collaboration with J&JPRD and the potential for Sunesis to receive additional milestone payments and royalties from J&JPRD. These forward-looking statements involve risks and uncertainties. Sunesis' actual results could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the risk that J&JPRD's research and development activities with respect to collaboration compounds could be halted or delayed for various reasons or that there may never be sales from a resulting product. Sunesis may never receive any additional milestone payments or royalties from J&JPRD in connection with this collaboration. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' annual report on Form 10-K for the year ended December 31, 2006, Sunesis' most recent quarterly report on Form 10-Q and other filings with the Securities and Exchange Commission. Sunesis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.


'/>"/>
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
2. Sunesis Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
4. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
5. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, February 27, 2008
6. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
7. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
8. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
9. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
10. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
11. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...NY, N.J., Nov. 5 DSM Pharmaceutica...facturing alliance with Galenix, Saint Jean D,Illa...ial scale manufacturing partner for Galenix commer...enix will collaborate on business development oppo...ologies, based on the strength of Galenix in drug ...
(Date:11/5/2009)...ORDOVA, Calif., Nov. 5 T...plier of innovative products for processing and st... the first quarter of fiscal 2010. ,, For the q...ted revenues of $5.2 million, a 15 percent increas...er a year ago. The Company said the key contributo...
(Date:11/5/2009)...eb., Nov. 5 Transgenomic...financial results for the quarter ended September ...ented in the tables that follow. ,, Third Quar... $366,000 or $0.01 per share for the third quarter...$0.01 per share for the third quarter of 2008. ,...
(Date:11/5/2009)...E, Calif., Nov. 5 Cephei...ives will be speaking at the following investor co...a webcast. , , Credit Suisse Healt...rsday, 12 November, 2009 at 10 a.m. Mountain Time,..., London, England, Tuesday, 1 Dece...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2
... Aug. 20 GSI Group Inc.,(Nasdaq: GSIG ) announce...iod of the tender offer by its indirect wholly-own...for all outstanding shares of common stock of,Exce...ffering period expired,as scheduled, at 12:00 midn...08., The depositary for the offer has advised GSI...
... Pixel Bridge, a Boston-based interacti...ounced the launch of a new website for Anika Thera...peutics (NASDAQ: ANIK) develops products that addr...halmic, veterinary and anti-adhesion markets. The ...develop and implement the new site. , ...
... from the National Institute of Standards and Tech...), a collaborative center of the University of Mar...ne the light coming from quantum dots by manipulat...blished in Physical Review Letters ,* could signi... of entangled photons, a property with important a...
Other Biology Technology:GSI Group Accepts Shares in Tender Offer for Excel Technology and Commences Subsequent Offering Period 2GSI Group Accepts Shares in Tender Offer for Excel Technology and Commences Subsequent Offering Period 3Pixel Bridge Works With Anika Therapeutics to Launch New Website 2Pixel Bridge Works With Anika Therapeutics to Launch New Website 3Light touch: Controlling the behavior of quantum dots 2
(Date:11/5/2009)...niversity has been awarded a training grant in the...dation under its Integrative Graduation Education ... first IGERT grant to be awarded to Kent State. Th...ry and Reinvestment Act of 2009, runs through 2014...s on environment aquatic resource sensing (EARS). ...
(Date:11/4/2009)...C - Lowly bacteria, it turns out, hold the power t...ts around the world clean up toxic waste on test s...lly RDX, were invented back in World War II and ha...hese high-energy compounds are often used to prope... of TNT. , But with increased knowledge of the...
(Date:11/4/2009)...CITY, Calif., Oct. 20 DigitalPerso...hentication solutions, today announced that WAND C...OS) software for quick-service restaurants, has in...Gen POS and Classic POS solutions. WAND,s quick-se... to boost cashier accountability and deter unautho...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Genomic research will enable greener cleanup of military explosive test sites 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 317 million US children live more than an hour away from trauma care 47486 117 million US children live more than an hour away from trauma care 47486 2Quality and purity of popular stevia sweetener strengthened by new reference standards 8677 1Quality and purity of popular stevia sweetener strengthened by new reference standards 8677 2BCBSNC Customers Save Millions and Stay on Medications with Free Generics Program 47480 1BCBSNC Customers Save Millions and Stay on Medications with Free Generics Program 47480 2BCBSNC Customers Save Millions and Stay on Medications with Free Generics Program 47480 3
...euroscientists have been indoctrinated into believ...nts are orchestrated by a communication network of...aying one specific chemical message called a neuro...tter that excites a neighboring cell, thereby trig... activity, or they dispatch a signal that quells a...
...sue of Biology of Reproduction includes a special ...hat delayed motherhood in mice results in shorter ...ffspring. , Negative effects of late maternal age ...in their children, are well known. However, other ...ed motherhood have been only anecdotal. , In what...
...cades after it burst onto the scene, HIV/AIDS has ...es to devastate societies around the world, partic...n the late 1980s and early 1990s, after years of e...lass of drugs that proved to be highly effective a... enzyme HIV protease, these protease inhibitors br...
Other Biology News:Researchers make surprise discovery that some neurons can transmit three signals at once 2Researchers make surprise discovery that some neurons can transmit three signals at once 3Supercomputers to focus brains on AIDS dilemma 2Supercomputers to focus brains on AIDS dilemma 3Supercomputers to focus brains on AIDS dilemma 4
Rabbit Anti-Yaf9 Polyclonal Antibody, Unconjugated from Abcam
... and perform Heat Induced Antigen Retrieval (HIER)...ns mounted on glass microscope slides. Deparffiniz...he high temperature used in HIER (over 90degrees C...ergent. Formaldehyde fixation impairs or totally d...
Fetal Calf Serum Replacement (Bistec) serum from Equitech-Bio
TE Buffer from EPICENTRE Biotechnologies
Biology Products: